A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)
A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)
Not yet recruiting · NCT07832201 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG) | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Not yet recruiting | Phase 4 | 2026-09-21 | NCT07832201 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sinovac Biotech Co., Ltd | 19 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chengdu Women's and Children's Central Hospital | Chengdu | China | 3 |
| Hunan Provincial Maternal and Child Health Care Hospital | Changsha | China | 1 |
| Nanfang Hospital, Southern Medical University | Guangzhou | China | 15 |
| Nanjing Drum Tower Hospita | Nanjing | China | 1 |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing | China | 34 |
| Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 11 |